Get the Stockscreener App
18.62
3.44%
0.62
After Hours:
18.52
-0.10
-0.54%
Procept Biorobotics Corp stock is traded at $18.62, with a volume of 1.18M.
It is up +3.44% in the last 24 hours and down -17.54% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$18.00
Open:
$18.01
24h Volume:
1.18M
Relative Volume:
0.74
Market Cap:
$1.06B
Revenue:
$322.02M
Net Income/Loss:
$-102.47M
P/E Ratio:
-10.18
EPS:
-1.8295
Net Cash Flow:
$-80.57M
1W Performance:
+11.56%
1M Performance:
-17.54%
6M Performance:
-35.70%
1Y Performance:
-61.62%
1-Day Range:
$17.71
$18.67
1-Week Range:
$16.86
$18.67
52-Week Range:
$16.66
$51.18
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
18.62 | 1.01B | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
UBS Downgrades PROCEPT BioRobotics to Neutral From Buy, Cuts Price Target to $20 From $30 - marketscreener.com
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights - Supply Chain Digital
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - AOL.ca
PROCEPT BioRobotics Corporation Revenue Breakdown – BOATS:PRCT - TradingView
INVESTOR ALERT: Securities Class Action Filed Against PROCEPT BioRobotics Corporation – Investors Encouraged to Contact Kirby McInerney LLP - Business Wire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - marketscreener.com
Law Offices of Howard G. Smith Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action - WBOC TV
Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Notice to Long-Term Shareholders of Cogent Communications - GlobeNewswire
Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Photronics, Inc. (NASDAQ: PLAB); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Class action lawsuit filed against PROCEPT BioR... - Pluang
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT - GlobeNewswire
Procept Biorobotics Corp (PRCT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Procept BioRobotics faces class action lawsuit over inflated sales and undisclosed inventory issues. - Pluang
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit - PR Newswire
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Class action lawsuit alleges PROCEPT BioRobotics inflated revenue via aggressive discounting. - Pluang
Procept BioRobotics: Filling Robots Slower Than Placing Them (NASDAQ:PRCT) - Seeking Alpha
Procept Biorobotics Corp (PRCT) Cash Flow - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.700|Chg%:+1.010 - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.480| - TradingKey
Procept Biorobotics Corp (PRCT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Procept Biorobotics Corp (PRCT) Institutional Confidence - TradingKey
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm - The Daily Tribune News
Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.250|Chg%:+0.560 - TradingKey
Procept Biorobotics Corp. (PRCT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Procept Biorobotics Corp. (PRCT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Procept Biorobotics Corp (PRCT) Income Statement - TradingKey
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses - The AI Journal
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files - GlobeNewswire
Procept Biorobotics Corp (PRCT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Procept Biorobotics stock hits 52-week low at $17.95 By Investing.com - Investing.com South Africa
Procept Biorobotics stock hits 52-week low at $17.95 - Investing.com
PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT) - The Globe and Mail
PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap? - Sahm
Mobia Medical (MOBI) names ex-PROCEPT CEO Reza Zadno as director - Stock Titan
Procept Biorobotics Corp stock hits 52-week low at 19.2 USD - Investing.com Nigeria
PROCEPT BioRobotics to report Q2 2026 results on August 4 - scanx.trade
Procept Biorobotics Corp stock hits 52-week low at 19.2 USD By Investing.com - Investing.com South Africa
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 - The Manila Times
PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 - Moomoo
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits
Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN
Pooja Sharma Net Worth (2026) - GuruFocus
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT) - The Globe and Mail
PROCEPT BioRobotics stock stays guided by procedure demand - AD HOC NEWS
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 - marketscreener.com
PRCTProcept BioRobotics Corp Dividends - Finviz
Truist cuts Procept BioRobotics stock rating on reimbursement concerns By Investing.com - Investing.com Nigeria
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Procept Biorobotics Corp Stock (PRCT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Waters Kevin | EVP, CFO |
Jun 08 '26 |
Sale |
28.48 |
357 |
10,167 |
151,201 |
| Templin Barry L | EVP, Chief Technology Officer |
Jun 08 '26 |
Sale |
28.48 |
358 |
10,195 |
68,953 |
1.04%
11.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):